University of Maryland, College Park, 4094 Campus Drive, College Park, MD, USA.
HIV Mental Health Research Unit, Division of Neuropsychiatry, Department of Psychiatry and Mental Health, Anzio Road, Groote Schuur Hospital, Observatory, University of Cape Town, Cape Town, South Africa.
Int J Drug Policy. 2019 Aug;70:61-69. doi: 10.1016/j.drugpo.2018.11.004. Epub 2019 May 10.
South Africa is home to the largest number of people living with HIV/AIDS in the world. Alongside the HIV/AIDS epidemic, problematic alcohol and other drug (AOD) use is prevalent and associated with poor HIV treatment and secondary HIV prevention outcomes. International guidelines and local policy both support the integration of mental health care and AOD treatment into HIV care, yet barriers exist to implementation. This study aimed to explore patient and provider perspectives on the integration of HIV and AOD treatment services in Cape Town, South Africa. This included barriers and facilitators to task sharing AOD treatment in HIV care and preferences for a task shared approach to integrating AOD treatment in HIV care, including who should deliver the behavioural intervention. We conducted thirty semi-structured qualitative interviews with HIV and AOD treatment staff, providers, and people living with HIV/AIDS (PLWH) with moderate, problematic AOD use and difficulties (personal or structural) adhering to HIV treatment. Findings illustrated several key themes: (1) the separation between AOD and HIV services (a "siloed treatment experience"), even in the context of geographic co-location; (2) low AOD treatment literacy among HIV patients and providers, including a low awareness of existing AOD use services, even when co-located; (3) substance use stigma as a barrier to HIV and AOD treatment integration; (4) a strong patient preference for peer interventionists; and (5) the role of community health workers (CHWs) in detecting AOD use among some PLWH who had not followed up in HIV care. These findings will inform a future type 1 hybrid effectiveness-implementation trial, guided by the RE-AIM framework, to evaluate a task shared, evidence-based intervention to address problematic AOD use and improve HIV medication adherence in this setting.
南非是世界上艾滋病毒/艾滋病感染者人数最多的国家。除了艾滋病毒/艾滋病疫情外,问题性酒精和其他药物(AOD)的使用也很普遍,并且与艾滋病毒治疗效果不佳和二级预防结果不佳有关。国际准则和当地政策都支持将精神保健和 AOD 治疗纳入艾滋病毒护理,但在实施方面存在障碍。本研究旨在探讨南非开普敦艾滋病毒和 AOD 治疗服务整合方面的患者和提供者观点。其中包括在艾滋病毒护理中分担 AOD 治疗任务的障碍和促进因素,以及对整合 AOD 治疗的偏好,包括谁应该提供行为干预。我们对 30 名艾滋病毒和 AOD 治疗工作人员、提供者以及有中度、问题性 AOD 使用和难以(个人或结构性)坚持艾滋病毒治疗的艾滋病毒感染者/艾滋病患者进行了半结构化定性访谈。研究结果说明了几个关键主题:(1)AOD 和艾滋病毒服务的分离("孤立的治疗体验"),即使在地理位置相邻的情况下也是如此;(2)艾滋病毒患者和提供者的 AOD 治疗知识水平低,包括对现有 AOD 使用服务的认识低,即使是在地理位置相邻的情况下;(3)物质使用耻辱感是艾滋病毒和 AOD 治疗整合的障碍;(4)患者强烈偏好同伴干预者;以及(5)社区卫生工作者(CHWs)在发现一些未在艾滋病毒护理中跟进的 PLWH 中使用 AOD 的作用。这些发现将为未来的 1 型混合有效性-实施试验提供信息,该试验将以 RE-AIM 框架为指导,评估一种分担任务、基于证据的干预措施,以解决该环境中的问题性 AOD 使用问题并提高艾滋病毒药物依从性。